共 80 条
[1]
Michalek IM(2017)A systematic review of worldwide epidemiology of psoriasis J Eur Acad Dermatol Venereol 31 205-212
[2]
Loring B(2012)Prevalence of psoriasis in China: a population-based study in six cities Eur J Dermatol 22 663-667
[3]
John SM(2019)Joint AAD–NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities J Am Acad Dermatol 80 1073-1113
[4]
Ding X(2017)Efficacy and safety of adalimumab every other week versus methotrexate once weekly in children and adolescents with severe chronic plaque psoriasis: a randomised, double-blind, phase 3 trial Lancet 390 40-49
[5]
Wang T(2020)Comparison of biologics and oral treatments for plaque psoriasis: a meta-analysis JAMA Dermatol 156 258-269
[6]
Shen Y(2019)Joint AAD–NPF guidelines of care for the management and treatment of psoriasis with biologics J Am Acad Dermatol 80 1029-1072
[7]
Elmets CA(2020)British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update Br J Dermatol 183 628-637
[8]
Leonardi CL(2019)Guideline for the diagnosis and treatment of psoriasis in China (2018 complete edition) Chin J Dermatol 52 667-710
[9]
Davis DMR(2006)Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study J Am Acad Dermatol 55 598-606
[10]
Papp K(2008)Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial J Am Acad Dermatol 58 106-115